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Background: Nicotine is a risk factor for pancreatitis resulting in loss of pancreatic enzyme secretion. The aim of
this study was to evaluate the mechanisms of nicotine-induced secretory response measured in primary pancreatic
acinar cells isolated from Male Sprague Dawley rats. The study examines the role of calcium signaling in the
mechanism of the enhanced secretory response observed with nicotine exposure.
Methods: Isolated and purified pancreatic acinar cells were subjected to a nicotine exposure at a dose of 100 μM
for 6 minutes and then stimulated with cholecystokinin (CCK) for 30 min. The cell’s secretory response was
measured by the percent of amylase released from the cells in the incubation medium Calcium receptor
antagonists, inositol trisphosphate (IP3) receptor blockers, mitogen activated protein kinase inhibitors and specific
nicotinic receptor antagonists were used to confirm the involvement of calcium in this process.
Results: Nicotine exposure induced enhanced secretory response in primary cells. These responses remained
unaffected by mitogen activated protein kinases (MAPK’s) inhibitors. The effects, however, have been completely
abolished by nicotinic receptor antagonist, calcium channel receptor antagonists and inositol trisphosphate (IP3)
receptor blockers.
Conclusions: The data suggest that calcium activated events regulating the exocytotic secretion are affected by
nicotine as shown by enhanced functional response which is inhibited by specific antagonists. . . The results
implicate the role of nicotine in the mobilization of both intra- and extracellular calcium in the regulation of
stimulus-secretory response of enzyme secretion in this cell system. We conclude that nicotine plays an important
role in promoting enhanced calcium levels inside the acinar cell.
Keywords: Isolated pancreatic acinar cell, Nicotine, Receptor blocker, Calcium channel antagonists, MAPK kinase
inhibitorsIntroduction
Smoking is an independent risk factor for development of
chronic pancreatitis and pancreatic cancer [1-6]. Studies
also show that nicotine plays a significant role in the in-
duction of pancreatic pathophysiology [7-12]. The
mechanism of this effect of nicotine on the pancreas
remains elusive and has not been established yet. We
have designed the current study in freshly isolated pan-
creatic acinar cells to determine the direct effect of
nicotine on exocrine secretory capacity by manipulating
calcium selective agents and mitogen activated protein* Correspondence: PChowdhury@uams.edu
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distribution, and reproduction in any mediumkinase (MAPK) inhibitors since in-vivo studies have
shown that nicotine at pharmacological concentrations
decrease exocrine function via suppression of amylase
release [7,11,13-15]. It is suspected that these effects
are most likely mediated via calcium regulated path-
ways [9,16,17]. However, no confirmatory studies have
been reported. In the current study we confirm that
these effects are regulated by calcium signaling as
calcium-selective inhibitors suppressed the nicotine-
induced pancreatic secretory response. The rationale
for the selection of various calcium sensing antagonists
for the study has been briefly described. Our major hy-
pothesis is that while calcium is important in regulating
the normal exocytotic secretory processing, excess
intracellular calcium that is produced with nicotineed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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pancreatic function leading to inflammation [7-9].
While Ca2+ could be released from the [Ca2+]I stores
including store –operated calcium channels, activation
of inositol-1,4,5-trisphosphate (IP3) receptors, found at
the cellular membrane, results in an elevation of [Ca2+]i
[18]. 2-Aminoethoxydiphenyl borate (2-APB) is a reliable
blocker of store-operated Ca2+ entry as well as an inhibi-
tor of InsP3-induced Ca
2+ release [19]. α-conotoxins are
tightly folded miniproteins that antagonize nicotinic
acetylcholine receptors (nAChR) with high specificity for
diverse subtypes. ω-conotoxin inhibits N-type voltage-
dependent calcium channels [20]. H-7 dihydrochloride is
a broad-based, cell-permeable serine/threonine kinase
inhibitor and has often been used to assess the contribu-
tion to cellular processes, including the induction of
gene expression. H-7 inhibits PKC more potently in in-
vitro assays and is mainly used as a rather nonspecific
inhibitor of protein kinase activity [21]. Mecamylamine
(inversine) is a nonselective and noncompetitive antag-
onist of the nicotinic acetylcholine receptors and it
blocks the effect of nicotine [22,23].
Material and methods
Reagents
All reagents used in the experiment are of analytical
grade. Nicotine was purchased from Sigma (St. Louis,
MO) and it was obtained in liquid form. Nicotine was
dissolved initially with a few drops of ethanol and fur-
ther diluted to the required concentration with saline,
pH adjusted to 7.4 by sodium hydroxide (1M). For con-
trol samples, medium containing the same amount of
ethanol was used as was done for dissolution of nicotine
with saline, the pH adjusted to 7.4. Cholecystokinin
(CCK-8) was purchased from Bachem, Philadelphia, PA.
For inhibitor studies, MAPK inhibitor, UO126, jun-
kinase inhibitor and p-38 kinase inhibitors were pur-
chased from (Cell Signaling Technology, Inc., Beverly,
MA). 2-Aminoethoxydiphenyl borate (2-APB), a reliable
blocker of store-operated Ca2+ entry and H-7, a broad-
based, cell-permeable serine/threonine kinase inhibitor,
were purchased from Calbiochem (San Diego, California).
Mecamylamine, a nicotinic acetylcholine receptor antag-
onist, was purchased from Sigma Life Sciences (St. Louis,
MO). ω-conotoxin, an N-type voltage-dependent calcium
channels inhibitor was purchased from Peptide Inter-
national (Louisville, Kentucky).
Isolation of primary pancreatic acinar cells
Adult male Sprague Dawley rats were used for the study.
The animals were procured through a protocol approved
by the Institutional Animal Care and Use Committee.
The animals were acclimatized for a week under con-
trolled laboratory conditions prior to the study. After an18-hour fast, the animals were sacrificed, the pancreas
removed quickly and freed from fat and lymph nodes.
Pancreatic acini were isolated by enzymatic digestion
according to methods reported previously [17,24,25].
Briefly, Krebs-Henseleit bicarbonate buffer, pH 7.4
(KHB), containing the minimum Eagle’s Medium supple-
ment (MEM), 67 U/ml collagenase, 2 mg/ml bovine
serum albumin (BSA), and 0.1 mg/ml soybean trypsin
inhibitor, was injected into the pancreatic tissue intersti-
tium. The injected pancreatic tissue was incubated at 37°C
in a shaking water bath at a frequency of 120 times/min
for 40 minutes, followed by mechanical disruption of the
tissue with gentle suction through pipettes of decreasing
orifice sizes. Acini were then purified by filtration through
150 μM polyethylene mesh and by density gradient centri-
fugation with KHB containing 4% BSA. Acini were prein-
cubated for 30 minutes in HEPES-buffered Ringer’s
solution, pH 7.4 (HR). The HR used was the same as
KHB, except that it contained 10 mmol/L Hepes and 0.5%
BSA. Prior to use, the buffer was gassed with 100% O2.
After pre-incubation, acini were washed and resuspended
in fresh HR at a density of 0.3-0.4 mg/ml of acinar
protein.
Primary cell culture
The purified primary acinar cells were maintained over-
night in 100 mm culture dish at concentration of 1.6 X
106/10 ml in culture media containing Ham’s F-12 nutri-
ent medium (F12K) with 2 mM L-glutamine, 1% anti-
biotic, 1.5% sodium bicarbonate, and 10% fetal bovine
serum albumin (FBS) at 37°C in a 5% CO2/95% air at-
mosphere. On day one, the medium was changed to a
serum-free nutrient medium.
Treatment of cells with nicotine
The cells were treated with 10 μM to 500 μM of nicotine
(Sigma, St. Louis, MO) in 6.0 ml of serum-free medium for
periods of 30 seconds to 10 minutes. Cells were pretreated
with inhibitors for 30 minutes before adding nicotine.
Amylase secretion from primary cells after nicotine
treatment
Cell function studies were performed with or without
CCK (Bachem, Philadelphia, PA) at its maximal, previ-
ously determined stimulating dose. These studies were
conducted with primary cells that were washed free of
media with Hepes-Ringer (HR) buffer, pH 7.4 (2X),
incubated in the same buffer with or without nicotine
(50 μM to 1000 μM) for periods of 0 to 10 minutes and
then washed twice with HR buffer to make the cells nico-
tine-free. The cells were then dispersed in fresh HR buffer,
incubated with or without CCK (10-9 M) for 30 minutes
at 37°C. The selection of this dose of CCK (10-9 M) for
was based on our initial study, which showed a maximal
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response curve [14]. Following the incubation period, the
media was removed by centrifugation and analyzed for
amylase activity by the method of [26] with Procion yellow
starch as substrate (PRO Chemical & Dye, Somerset,
MA). Cell pellets were washed with ice-cold PBS, lysed
with water by sonication, and centrifuged. The cell lysate
was analyzed for both amylase and protein content. Pro-
tein concentration was measured by the method of [27].
The amylase release was expressed as the fractional
amount (%) released from the total.
Effect of mecamylamine or conotoxin on primary cell
function, with or without nicotine
Primary cells (4–6 x 106) were washed and incubated at
37°C with or without 500 μM mecamylamine for 30
minutes, followed by an additional incubation with nico-
tine for 6 minutes. Cells were washed and then incu-
bated at 37°C with or without CCK-8 (10-9 M) for 30
minutes. Amylase released into the incubation mediumFigure 1 Primary cells were washed, incubated at 37°C with 100 μM n
of nicotine (Panel B) and then incubated with CCK-8 (10-9) M, or with
measured with Procion-yellow starch as substrate. The data are presented
separate experiments (unstimulated, circles with solid line); (stimulated, triawas measured with Procion-yellow starch as substrate.
The data are presented as % initial content and repre-
sented as the mean ± SEM of four experiments.
For conotoxin experiment, primary cells (4–6 x 106)
were washed and incubated at 37°C without or with 80
mM conotoxin for 30 minutes, followed by additional 6
minutes incubation with nicotine. The rest of the pro-
cedure was similar as described above.
Effect of H-7 on primary cell function, with or without
nicotine
Primary cells (4–6 x 106) were washed and incubated at
37°C with or without 10 μM H-7 for 30 minutes, fol-
lowed by an additional incubation with nicotine for 6
minutes. Cells were washed and then incubated at 37°C
with or without CCK-8 (10-9 M) for 30 minutes. Amyl-
ase released into the incubation medium was measured
with Procion-yellow starch as substrate. The data are
presented as % initial content and represented as the
mean ± SEM of four experiments.icotine for 0 to 10 minutes (Panel A) or at various concentrations
out CCK-8 for 30 minutes. Amylase released into the medium was
as % initial content and represented as the mean ± SEM of four
ngles with dashed line).
Figure 2 Effect of mecamylamine or conotoxin on primary cell function, with or without nicotine. Panel A: Primary cells (4–6 x 106) were
washed and incubated at 37°C with or without 500 μM mecamylamine for 30 minutes, followed by an additional incubation with nicotine for 6
minutes. Cells were washed and then incubated at 37°C with or without CCK-8 (10-9 M) for 30 minutes. Amylase released into the incubation
medium was measured with Procion-yellow starch as substrate. The data are presented as % initial content and represented as the mean ± SEM
of four experiments. Panel B: Primary cells (4–6 x 106) were washed and incubated at 37°C without or with 80 mM conotoxin for 30 minutes,
followed by additional 6 minutes incubation with nicotine. The rest of the procedure was similar to panel A. The data are presented as % initial
content and represented as the mean ± SEM of four experiments. *P < .05 between control and nicotine-added samples; **P < .05 between
nicotine-added and mecamylamine + nicotine-added or conotoxin + nicotine added samples.
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or without nicotine
Primary cells (4–6 x 106) were washed and incubated at
37°C without or with 80 mM 2-APB for 30 minutes, fol-
lowed by an additional 6 minutes incubation with nico-
tine. Amylase released into the incubation medium was
measured with Procion-yellow starch as substrate. The
data are presented as % initial content and represented
as the mean ± SEM of four experiments.
Effect of ERK Inhibitor on primary cell function with or
without nicotine
To study the effect of an ERK1/2 inhibitor on basal and
stimulated amylase release, primary cells were pretreated
with UO126 (10 μM) for 30 minutes. After washing, the
cells were incubated with 100 μM nicotine for 6 min-
utes. At the end of the incubation period, the cells were
washed with HR buffer, and incubated with either buffer,
or buffer containing 10-9 M CCK-8, for 30 minutes.
Amylase release in the media and protein concentration
were determined as outlined in the earlier section. Themethod used for CCK stimulation was similar to that
described in the earlier section.
Effect of JNK inhibitor or p38 inhibitor on primary cell
function, with or without nicotine
Primary cells (4–6 x 106) were washed and incubated at
37°C with or without 100 nM JNK inhibitor or with 1 μM
p38 kinase inhibitor for 30 minutes, followed by an add-
itional incubation with nicotine for 6 minutes. Cells were
washed and then incubated at 37°C with or without CCK-
8 (10-9 M) for 30 minutes. Amylase released into the incu-
bation medium was measured with Procion-yellow starch
as substrate. The data are presented as % initial content
and represented as the mean ± SEM of four experiments.
Statistics
Results were reported as mean ± standard error of the
mean (SEM). The results were analyzed by student’s t-test
and where required, with analysis of variance (ANOVA).
Differences were considered significant at a probability of
0.05 or lower.
Figure 3 Effect of H-7 or 2-APB on primary cell function, with or without nicotine. Panel A: Primary cells (4–6 x 106) were washed and
incubated at 37°C with or without 10 μM H-7 for 30 minutes, followed by an additional incubation with nicotine for 6 minutes. Cells were
washed and then incubated at 37°C with or without CCK-8 (10-9 M) for 30 minutes. Amylase released into the incubation medium was measured
with Procion-yellow starch as substrate. The data are presented as % initial content and represented as the mean ± SEM of four experiments.
Panel B: Primary cells (4–6 x 106) were washed and incubated at 37°C without or with 80 mM 2-APB for 30 minutes, followed by an additional 6
minutes incubation with nicotine. Amylase released into the incubation medium was measured with Procion-yellow starch as substrate. The data
are presented as % initial content and represented as the mean ± SEM of four experiments. *P < .05 between control and nicotine-added samples;
**P < .05 between nicotine-added and H-7 + nicotine-added or 2-APB + nicotine added samples.
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Nicotine Effects on CCK-stimulated acinar cell function
The time and nicotine dose effects on maximal stimu-
lated amylase release in response to CCK are shown in
Figure 1. The solid line represents the amylase response
of control cells while the broken line represents the sti-
mulated amylase response by CCK at a maximal stimu-
lating dose of 10-9 M [14]. The bottom panel in Figure 1
shows that nicotine at a dose of 100 uM induced max-
imal release of amylase (Panel B) while the upper panel
(Panel A) shows that the maximal response occurring at
3 mins of exposure that persisted until 6 min before de-
cline. Based on this observation, a single dose of nicotine
(100 uM) and time of exposure for 6 min was used in
subsequent experiments on the results as shown below.
Effect of mecamylamine or conotoxin on primary cell
function, with or without nicotine
The effects of nicotine in the presence or absence of
mecmylamine, and conotoxin on the basal and cell sti-
mulated primary acinar cell function are shown in Figure 2.The upper panel (panel A) represents the basal and stimu-
lated amylase release in the presence of mecamylamine
while the lower panel (panel B) represents the effect of
conotoxin. As shown in panel A, the basal levels of amylase
release was increased significantly in the presence of nico-
tine when compared to control levels and reduced signifi-
cantly in the presence of mecamylamine. Stimulation with
CCK-8 enhanced the levels of amylase release in all groups.
Treatment with nicotine induced CCK stimulated levels
more than the control group. However, in the presence of
mecamylamine, the enhanced response induced by nico-
tine was completely abolished returning the stimulated
levels to that of control level. The response of acinar cell to
amylase release by nicotine in the presence of conotoxin is
identical to that of mecamylamine (Panel B).
Effect of H-7 or 2-APB on primary cell function, with or
without nicotine
The effects of nicotine in the presence or absence of H-7,
and 2-APB on the basal and cell stimulated primary acinar
cell function are shown in Figure 3. The upper panel
Figure 4 Effect of AKT inhibitor or ERK1/2 inhibitor on primary cell function, with or without nicotine. Panel A: Primary cells
(4–6 x 106) were washed and incubated at 37°C with or without 50 μM AKT inhibitor for 30 minutes, followed by an additional incubation with nicotine
for 6 minutes. Cells were washed and then incubated at 37°C with or without CCK-8 (10-9 M) for 30 minutes. Amylase released into the incubation medium
was measured with Procion-yellow starch as substrate. The data are presented as % initial content and represented as the mean± SEM of four experiments.
Panel B: Primary cells (4–6 x 106) were washed and incubated at 37°C without or with 10 μM UO126 for 30 minutes, followed by an additional 6 minutes
incubation with nicotine. Amylase released into the incubation medium was measured with Procion-yellow starch as substrate. The data are presented as %
initial content and represented as the mean± SEM of four experiments. *P < .05 between control and nicotine-added samples.
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lease in the presence of H-7 while the lower panel (panel
B) represents the effect of 2-APB. As shown in panel A,
the basal levels of amylase release were similar in all four
groups. Stimulation with CCK-8 enhanced the levels of
amylase release in all groups. Treatment with nicotine
induced CCK stimulated levels more than the control
group. However, in the presence of H-7, or 2-APB the
enhanced response induced by nicotine was completely
abolished and returned to stimulated value as of control.
The response of acinar cell to amylase release by nicotine
in the presence of H-7 (Panel A) is identical to that of
2-APB (Panel B).
Effect of ERK and AKT Inhibitor on primary cell function
with or without nicotine
The effects of nicotine in the presence or absence of
MAPK inhibitors, UO126, and AKT on the basal and
cell stimulated primary acinar cell function are shown in
Figure 4. The upper panel (panel A) represents the basal
and stimulated amylase release in the presence of AKTinhibitor while the lower panel (panel B) represents the
effect of UO126. As shown in panel A, the basal levels
of amylase release were similar in all four groups. Upon
stimulation with CCK-8, levels of amylase release were
enhanced significantly in all groups in all groups. Treat-
ment with nicotine induced CCK stimulated levels more
than the control group. However, in the presence of
AKT inhibitor, or UO126, the enhanced response
induced by nicotine remained unaltered. The response
of acinar cell to amylase release by nicotine in the pres-
ence of AKT inhibitor (Panel A) is identical to that of
UO126 (Panel B).
Effect of JNK inhibitor or p38 inhibitor on primary cell
function, with or without nicotine
The effects of nicotine in the presence or absence of
MAPK inhibitors, JNK, and p38 kinase inhibitors on the
basal and cell stimulated primary acinar cell function are
shown in Figure 5. The upper panel (panel A) represents
the basal and stimulated amylase release in the presence
of JNK inhibitor while the lower panel (panel B)
Figure 5 Effect of JNK inhibitor or p38 inhibitor on primary cell function, with or without nicotine. Panel A: Primary cells (4–6 x 106) were
washed and incubated at 37°C with or without 100 nM JNK inhibitor for 30 minutes, followed by an additional incubation with nicotine for 6 minutes. Cells
were washed and then incubated at 37°C with or without CCK-8 (10-9 M) for 30 minutes. Amylase released into the incubation medium was measured with
Procion-yellow starch as substrate. The data are presented as % initial content and represented as the mean± SEM of four experiments. Panel B: Primary cells
(4–6 x 106) were washed and incubated at 37°C without or with 1 μM p38 inhibitor for 30 minutes, followed by an additional 6 minutes incubation with
nicotine. Amylase released into the incubation medium was measured with Procion-yellow starch as substrate. The data are presented as % initial content
and represented as the mean± SEM of four experiments. *P < .05 between control and nicotine-added samples.
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in panel A, the basal levels of amylase release were simi-
lar in all four groups. Upon stimulation with CCK-8
levels of amylase release were enhanced significantly in
all groupss. Treatment with nicotine induced CCK sti-
mulated levels more than the control group. However, in
the presence of JNK inhibitor, or p-38 kinase inhibitor,
the enhanced response induced by nicotine was not
changed. The response of acinar cell to amylase release
by nicotine in the presence of JNK inhibitor (Panel A) is
identical to that of p-38 kinase inhibitor (Panel B).
Discussion
The data presented in this communication demonstrates,
in part, the mechanism by which nicotine induced the
enhanced secretory response in pancreatic acinar cells
In earlier studies the effect of nicotine on cell signal-
ing and function in this cell system and in rat tumori-
genic cell line has been reported from this laboratory
[28-30]. However, the precise mechanism by which
nicotine induces the enhancement of the acinar cell
function was not shown. The initial focus of the currentstudy was to confirm the effects of nicotine on stimu-
lated secretory response in primary cells and then to
evaluate its mechanism. As shown in Figures (2–5),
nicotine treatment maximally increased basal and CCK-
stimulated enzyme secretions at 6 min of nicotine ex-
posure. The dose of nicotine used for the study was
identical to that was used in our earlier reported studies
[28-30]. The selection of the nicotine dose was based
on published literature reported both in in-vivo and
other cell culture studies [7,8,31-35]. Dose levels of
nicotine used in our study were below peak plasma
nicotine concentration found in chronic cigarette smo-
kers, which ranges from 10 to 15 mM, measured within
20 min of cigarette smoking [33]. In addition, in other
laboratories, nicotine doses at varying concentration
ranging from 0.75 mM to 25 mM have been used in iso-
lated rat pancreatic acini [34]. In our current study, a
lower nicotine dose of 100 uM, was used resulting in an
induction of maximal secretory response when exposed
for 3 min, which persisted for 6 min before decreasing
(Figure 1). This is consistent with our findings
published earlier.
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gen in acinar cell system by activating p-ERK 1 and 2
[28-30,36]. Our studies show that ERK1/2 is activated by
nicotine treatment under similar conditions and in the
presence of the nicotine receptor antagonist the stimula-
tory cell response remain unaffected, implying that the
kinase and secretory responses induced by nicotine are
completely independent of each other and, perhaps, in-
volve a separate mechanism. In this study we have
looked into the influence of MAPK activation by nico-
tine and its effects on cell function. As shown in Figures 4
and 5, mitogen activated protein kinases have no influence
on nicotine-induced CCK-stimulated cell function sug-
gesting that response of nicotine on cell function is regu-
lated by a mechanism not related to MAPK activation.
The effects of nicotine on basal and stimulated
secretory response are abolished by mecamylamine, a
nicotinic receptor antagonist, suggesting that the
secretory response of nicotine is receptor-mediated. It
has long been established that stimulation of enzyme
secretions by secretagogues in pancreatic acini involves
several second-messenger pathways that are rapidly acti-
vated by G-protein-coupled receptors [37-39] and changes
in intracellular calcium concentration [40,41] and may in-
volve a cell-mediated intracellular Ca2+ response [9,42].
In this study, the suppression of the secretory responses
by calcium selective antagonists as shown in Figures 2 and
3 indicates that enhanced secretion induced by nicotine is
triggered via calcium-activated process. Enhanced release
of calcium at pharmacological doses of nicotine may lead
to loss of pancreatic function resulting in pancreatic path-
ology [7-9]. Thus the studies may be clinically relevant to
the development of pancreatitis in smokers and will most
likely be based on nicotine dose derived from the number
of cigarettes smoked.
It has been reported that in rat sublingual mucous
acini, nicotine first triggers the release of acetylcholine
from pre-synaptic nerve terminals, which then activates
muscarinic receptors [43]. In this study, we have
observed that w-conotoxin, a potent Q-type calcium
channel blocker, completely inhibited nicotine-induced
pancreatic secretion suggesting that the regulation of
pancreatic secretion by nicotine is physiologically regu-
lated by a calcium-mediated process. The current study
has examined the specificity of the nicotinic receptor an-
tagonist in primary cells and has demonstrated that its
effect on downstream events regulating exocrine secre-
tion is regulated by calcium activated events involving
both intra and extracellular calcium mobilization.
It has been demonstrated that intracellular calcium
([Ca2+]i) signals are involved in a number of events, in-
cluding apoptotic pathways [44-46]. While Ca2+ could be
released from the [Ca2+]i stores, Ca
2+ also could enter
from the extracellular space through membrane channels.Recently it has been shown that the activation of inositol-
1, 4, 5-trisphosphate (IP3) receptors, found at the cellular
membrane, results in an elevation of [Ca2+] I [18]. The
modulation of [Ca2+]I influences the activation of calplain
[47], which controls cell-cycle regulation, differentiation
and apoptosis [48]. Activation of calpain from pro-calpain
leads to apoptosome formation by cleavage of Bid, which
in turn regulates Bax and activates caspase-3 [44,48].
Conclusions
In summary, our data suggest that calcium activated
events regulating the exocytotic secretion are affected by
nicotine inducing enhanced functional response as con-
firmed by the inhibitory actions of these specific antag-
onists. . . The results implicate the role of nicotine in the
mobilization of both intra- and extracellular calcium in
the regulation of stimulus-secretory response of enzyme
secretion in this cell system. We conclude that nicotine
plays an important role in promoting enhanced calcium
levels inside the acinar cell.
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